TX SB241 | 2023-2024 | 88th Legislature
Status
Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on May 27 2023 - 100% progression
Action: 2023-05-27 - Effective on . . . . . . . . . . . . . . . September 1, 2024
Text: Latest bill text (Enrolled) [HTML]
Spectrum: Bipartisan Bill
Status: Passed on May 27 2023 - 100% progression
Action: 2023-05-27 - Effective on . . . . . . . . . . . . . . . September 1, 2024
Text: Latest bill text (Enrolled) [HTML]
Summary
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
Title
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
Sponsors
Roll Calls
2023-05-12 - House - Read 3rd time RV#1580 (Y: 140 N: 0 NV: 2 Abs: 7) [PASS]
2023-03-23 - Senate - Read 3rd time (Y: 31 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-23 - Senate - Three day rule suspended (Y: 31 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-23 - Senate - Read 3rd time (Y: 31 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-23 - Senate - Three day rule suspended (Y: 31 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2023-05-27 | Effective on . . . . . . . . . . . . . . . September 1, 2024 | |
2023-05-27 | Signed by the Governor | |
2023-05-16 | Sent to the Governor | |
2023-05-16 | House | Signed in the House |
2023-05-16 | Senate | Signed in the Senate |
2023-05-15 | Senate | Reported enrolled |
2023-05-15 | Senate | House passage reported |
2023-05-12 | House | Nonrecord vote recorded in Journal |
2023-05-12 | House | Record vote RV#1580 |
2023-05-12 | House | Passed |
2023-05-12 | House | Read 3rd time |
2023-05-12 | House | Nonrecord vote recorded in Journal |
2023-05-12 | House | Passed to 3rd reading |
2023-05-12 | House | Read 2nd time |
2023-05-12 | House | Placed on Local, Consent, and Res. Calendar |
2023-05-10 | House | Considered in Local & Consent Calendars |
2023-05-08 | House | Comm. report sent to Local & Consent Calendar |
2023-05-07 | House | Committee report distributed |
2023-05-06 | House | Comte report filed with Committee Coordinator |
2023-05-03 | House | Reported favorably w/o amendment(s) |
2023-05-03 | House | Recommended to be sent to Local & Consent |
2023-05-03 | House | Considered in formal meeting |
2023-04-10 | House | Referred to Public Health |
2023-04-10 | House | Read first time |
2023-03-27 | House | Received from the Senate |
2023-03-23 | Senate | Reported engrossed |
2023-03-23 | Senate | Record vote |
2023-03-23 | Senate | Passed |
2023-03-23 | Senate | Read 3rd time |
2023-03-23 | Senate | Record vote |
2023-03-23 | Senate | Three day rule suspended |
2023-03-23 | Senate | Vote recorded in Journal |
2023-03-23 | Senate | Passed to engrossment as amended |
2023-03-23 | Senate | Vote recorded in Journal |
2023-03-23 | Senate | Amended |
2023-03-23 | Senate | Amendment(s) offered FA1 Perry |
2023-03-23 | Senate | Read 2nd time |
2023-03-23 | Senate | Rules suspended-Regular order of business |
2023-03-22 | Senate | Placed on intent calendar |
2023-03-20 | Senate | Committee report printed and distributed |
2023-03-20 | Senate | Recommended for local & uncontested calendar |
2023-03-20 | Senate | Reported favorably as substituted |
2023-03-15 | Senate | Vote taken in committee |
2023-03-15 | Senate | Testimony taken in committee |
2023-03-15 | Senate | Considered in public hearing |
2023-03-15 | Senate | Scheduled for public hearing on . . . |
2023-03-08 | Senate | No action taken in committee |
2023-03-08 | Senate | Scheduled for public hearing on . . . |
2023-02-15 | Senate | Referred to Health & Human Services |
2023-02-15 | Senate | Read first time |
2022-11-16 | Senate | Filed |
2022-11-16 | Senate | Received by the Secretary of the Senate |
Same As/Similar To
HB2529 (Same As) 2023-05-01 - Left pending in committee
HB2529 (Same As) 2023-05-01 - Left pending in committee
HB2529 (Same As) 2023-05-01 - Left pending in committee
Subjects
DIABETES
Health
HEALTH & HUMAN SERVICES COMMISSION
Health--Other Diseases & Medical Conditions
Insurance
Insurance--Health & Accident
MEDICINE & PRESCRIPTION DRUGS
Health
HEALTH & HUMAN SERVICES COMMISSION
Health--Other Diseases & Medical Conditions
Insurance
Insurance--Health & Accident
MEDICINE & PRESCRIPTION DRUGS